X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Americas

Ilc dover to unveil innovative new xtrakt™ bulk liquid dispensing system at pack expo

Yuvraj_pawp by Yuvraj_pawp
21st September 2017
in Americas, News

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

ILC Dover has announced that it will be conducting live demos of its new Xtrakt™ Bulk Liquid Dispensing System in Booth 6758 at Pack Expo, which will run from 9:00 a.m. to 4:00 p.m.daily, September 25–27, at the Las Vegas Convention Center, Las Vegas, NV. The revolutionary Xtrakt™ System represents the first completely new packaging and dispensing system developed by ILC Dover since its acquisition of Grayling Industries. The product is designed to boost profits and reduce waste for customers working in the personal care, chemical, and food industries.

 

In making the announcement, Glenn LeBlanc, V.P. & Division Manager for the Packaging & Personal Safety Division, noted, “Our project objective, which has been met very successfully, was to develop an easy-to-use system that could drastically reduce the residual material left in shipping and transfer tote liners after dispensing, especially for viscous liquids. By applying ILC’s expertise in engineering, processing system design, advanced materials and bulk packaging technology to our customers’ operational requirements, we were able to create a highly efficient dispensing system unlike any other on the market.”

The innovative, patent-pending system consists of three major components: the unique Xtrakt™ drive unit, the deployment cart and a custom-designed liquid liner. The system is optimized to dispense high-viscosity liquids, such as lotions, creams, lubricants, liquid polymers, oils and syrups from shipping and transfer totes (intermediate bulk containers, or IBCs). The ergonomic Xtrakt drive unit has been designed and tested to withstand thousands of dispense cycles while handling the rigors of the manufacturing environment. Drawing on their materials and design expertise, ILC Dover’s engineers have developed a double-walled liner constructed from a robust polymer with special surface texturing that guides the drive unit along the liner’s full length, continuously presenting product to the discharge pump.

 

Through rigorous multi-site performance testing, customer use of the product has demonstrated the system’s ability to reduce residual product in a bulk liner to as little as 0.1% of the liner’s capacity. Customers using the patent-pending Xtrakt system in their own facilities report residual product of less than 2 kg remaining in a typical 1,200-liter (315-gallon) liner, down from 10-40 kilos (22-88 pounds) of residual product left by previous dispensing systems and techniques.

 

LeBlanc added, “We’re confident Xtrakt™ is the first in a line of innovations we will introduce to support the cosmetic, food, and chemical industries going forward. As a corporation, we have challenged all of our operating entities to live up to our creed, which is to use our combined expertise and problem-solving creativity to redefine what’s possible.”

To see a live demonstration of the Xtrakt System, visit Booth 6758 at Pack Expo. For those not attending the show, detailed information about the system is available at www.ilcdover.com/xtrakt

About ILC Dover
Founded in 1947, ILC Dover specializes in the innovative design and production of carefully engineered products using high-performance flexible materials. Known for its production of spacesuits for NASA, its engineered solutions also include powder handling systems for pharmaceutical and life sciences applications, bulk packaging systems, personal protection equipment and lighter-than-air systems and vehicles for commercial and government customers. With facilities in North America and Europe, ILC has over 450,000 square feet of office, development and manufacturing space, and over 500 employees. Product and corporate information are available at www.ilcdover.com. Behrman Capital is the majority shareholder of ILC Dover.

For editorial information, contact:
Ted R. Arnold
Senior Account Supervisor
Aloysius Butler & Clark
302-655-1552
tarnold@abccreative.com

SOURCE ILC Dover

Related Links
http://www.ilcdover.com

News/Event Type:
Bulk Packaging and Processing
Grayling Industries
Xtrakt

Tags: America
Previous Post

New Nymalize Oral Solution 10 mL Unit Dose for the Treatment of Subarachnoid Hemorrhage launched by Arbor Pharma

Next Post

Juno Therapeutics Opens New Headquarters and Research Center

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post

Juno Therapeutics Opens New Headquarters and Research Center

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In